Low-grade MALT lymphoma mimicking Waldenströ m's macroglobulinemia

TO THE EDITOR
Low-grade B cell MALT lymphomas are characterized by a prolonged clinical course and persistent disease at the site of origin. These lymphomas disseminate in up to 30% of cases and preferentially invade other mucosal sites. 1 Bone marrow involvement seems uncommon but has been observed. 2 We report two cases of low grade gastrointestinal MALT lymphoma with bone marrow involvement and a high level of serum monoclonal IgM mimicking Waldenströ m's macroglobulinemia (WM).
A 31-year-old man presented with epigastric pain. Endoscopic examination disclosed antral ulcerations. Histopathological examination of gastric samples found infiltration by centrocyte-like cells, and lympho-epithelial lesions. These findings were highly suggestive of low-grade MALT lymphoma. Helicobacter pylori was not found. Blood chemistry, including serum electrophoresis, was normal. Bone marrow smear and biopsy were both normal. The patient received omeprazole and chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisone, every 4 weeks for 1 year. After 6 months of this chemotherapy, upper and lower gastrointestinal endoscopy with biopsies, as well as a second bone marrow biopsy, were all normal. Two months after the end of chemotherapy, the lymphoma relapsed in the stomach. Bone marrow biopsy and serum electrophoresis were again normal. Gastrectomy was performed. Histopathological examination of the stomach showed infiltration by centrocyte-like cells and for the first time, by numerous plasma cells. Immunohistochemical study found that tumoral cells were positive for and chains, CD19, CD20, CD22, CD23 and CD43; and negative for CD5, CD10. Cytogenetic study aimed to detect trisomy 3 was performed on gastric lymphoma. FISH procedure was performed as described elsewhere. 3 We detected 17% of nuclei showing three clearly separated chromosome territories and concluded that a trisomy 3 in gastric lymphoma cells was present. Three months later, the patient presented with an intestinal occlusion. CT scan showed a peritoneal mass. Biopsy of this mass confirmed relapse of the lymphoma, which was still low grade. On the serum electrophoresis, a peak of 29 g/l was found in the gammaglobulin fraction. It was identified by immunoelectrophoresis as an IgM component. At aspiration, the bone marrow was infiltrated by small lymphoid and lymphoplasmacytoid cells, as well as by plasma cells, a picture suggestive of Waldenström's macroglobulinemia. The patient was treated with intensive chemotherapy (120 mg/kg cyclophosphamide, 30 mg/kg etoposide) and total body irradiation, followed by autologous blood stem cell transplantation. Three years after autografting, he is in complete remission and the serum monoclonal IgM component has disappeared.
A 71-year-old man from Benin complained of epigastric pain and progressive weakness. On physical examination, he had epigastric tenderness but no lymphadenopathy or hepato- splenomegaly. A peak of gammaglobulin at 31 g/l was detected on serum electrophoresis and immunoelectrophoresis revealed the presence of an IgM component. Examination of a bone marrow aspirate and biopsy showed infiltration by a small-cell malignant lymphoma with plasmacytic differentiation suggestive of Waldenströ m's macroglobulinemia. Upper endoscopy revealed stenosis of 5 cm of the first part of the duodenum. Histopathological examination showed mucosal and submucosal infiltration by centrocyte-like cells and plasma cells, with monotypic staining for and light chains. A few lympho-epithelial lesions were also noted. All these findings were characteristic of low-grade MALT lymphoma. The patient received chemotherapy consisting of cyclophosphamide, vincristine and prednisone every 4 weeks for 6 months, followed by oral cyclophosphamide for 1 year. He improved clinically. The serum monoclonal IgM component remained stable at 31 g/l. A new endoscopic examination showed that the duodenal stenosis had regressed.
In these two cases, the tumor cells from MALT lymphoma expressed IgM on the surface membrane and in the cytoplasm with the same light chain type as that of the serum monoclonal IgM. These findings strongly suggest that serum monoclonal IgM was produced and secreted by cells from MALT lymphoma. The first patient had a MALT lymphoma with an unusual evolution. Initially, the patient's tumor was confined to the stomach and featured all the characteristics of lowgrade MALT lymphoma. However, the tumor subsequently disseminated to the lymph nodes and bone marrow, and produced a serum monoclonal component (IgM). At this stage of dissemination, as in the second case, differential diagnosis between low-grade MALT lymphoma and WM with gastrointestinal involvement was not possible on bone marrow examination. WM is usually defined as bone marrow infiltration of lymphoplasmacytoid lymphocytes with a high level of circulating macroglobulin IgM. 4 While lymphadenopathy and splenomegaly occur in 20-40%, invasion of the gastrointestinal tract is considered unusual, and has been reported to occur in 5-10%. 4 We postulate that some cases of WM with gastrointestinal involvement might in fact constitute disseminated forms of low-grade MALT lymphoma.
The difficulty in distinguishing WM with gastrointestinal involvement from MALT lymphoma with bone marrow involvement is underlined by the fact that these two disorders have many common morphologic and phenotypic features. 5 In low-grade MALT lymphoma, the tumor cells infiltrate the area corresponding to the marginal zone, and consist of small lymphoid B cells. These cells, called centrocyte-like cells because of their morphological resemblance to follicle centre centrocytes, tend to invade the mucosal epithelium and form characteristic lympho-epithelial lesions. Immunohistochemical analysis has shown that they express monotypic surface immunoglobulin, usually IgM (or in a few cases IgA). Similar to the marginal zone cells from which they are thought to arise, these centrocyte-like cells are positive for pan B cell antigens, and are negative for CD5 and CD10. This phenotype is also that of the B cells in WM, and thus, immunohistochemical study is not useful for differential diagnosis. Demonstration of trisomy 3 which has been found in up to 60% of MALT lymphomas 6 may be useful in this situation.
Recent studies regarding somatic hypermutation of immunoglobulin genes show that both MALT lymphoma and Waldenströ m's macroglobulinemia are tumors of hypermutated post germinal center B lymphocytes that have undergone antigen selection. 1, 7 All together, these data suggest a close relationship between these two entities from the perspective of cellular origin.
The maturation of small lymphoid cells into plasma cells, characteristic of Waldenströ m's macroglobulinemia, is also observed in 30-40% of low-grade MALT lymphomas. However, the appearance of a serum monoclonal component seems uncommon in MALT lymphoma. It has been reported in only one case of MALT lymphoma, 2 and seems much more common in the closely related nodal marginal zone B cell lymphomas. 6 The presence of a serum monoclonal component in MALT lymphoma might be due to extra-mucosal dissemination of the disease, especially in bone marrow, as illustrated in our first patient.
In conclusion, disseminated MALT lymphoma may mimick WM. Our observations suggest that some cases of MW with gastrointestinal involvement many in fact constitute disseminated forms of low-grade MALT lymphoma. Laboratoire de Pharmacologie J-C Brouet
